The global Coronary Stents Market is poised to achieve a valuation of US$ 51.2 million by 2032, with a steady CAGR of 5.1% anticipated during the period spanning 2022 to 2032. In the year 2022, the market is expected to attain an estimated worth of US$ 33.36 million. This growth is driven by several factors, …
Category Archives: Healthcare Trends
Alcohol Use Disorder Treatment Market: Shaping Futuristic Finances with a US$ 1,300 Million Valuation by 2033
According to a recent FMI study, the global Alcohol Use Disorder Treatment Market is expected to grow at a 6.4% CAGR between 2023 and 2033. By the end of the evaluation period, the market is expected to be worth US$ 1300 million. The growing number of drug awareness campaigns, prevention programmes, and technological advances all contribute to …
COVID-19 Vaccine Packaging and Delivery Devices Market: Empowering Immunization with a US$ 2.2 Billion Valuation Target in 2033
The COVID-19 Vaccine Packaging and Delivery Devices Market analysis report, just released by Future Market Insights, estimates that global sales of the Covid-19 Vaccine Packaging and Delivery Devices will reach US$ 1.1 billion in 2022. With a CAGR of 7.1% from 2023 to 2033, the market is anticipated to reach a valuation of US$ 2.2 …
Biliary Tract Cancer (BTCs) Treatment Market to Reach US$ 4.74 Billion by 2033, Growing at 4% CAGR, Driven By New Innovations in Early Detection and Treatment: FMI Study
The global Biliary Tract Cancers (BTCs) Treatment Market is anticipated to reach a market size of US$ 3.2 billion in 2023 and US$ 4.74 billion by exhibiting a CAGR of 4% from 2023 to 2033. From 2018 to 2022, the market for biliary tract cancers (BTCs) treatment experienced a 3% CAGR. BTCs are a group …
Disposable EEG Electrode Market: Sparking Electrifying Growth, Targeting US$ 1.2 Billion Valuation by 2033
According to Future Market Insights Disposable EEG Electrode Market analysis report, global sales of the Disposable EEG Electrode Market in 2022 will be US$ 782 million. The market is expected to reach a valuation of US$ 1.2 billion by 2033, with a CAGR of 4.3% from 2023 to 2033. Needle Electrodes are expected to be the most …
Myelofibrosis (MF) Treatment Market: Revealing Healing Horizons Towards US$ 1,280 Million by 2033
From 2023 to 2033, the global Myelofibrosis (MF) Treatment Market is expected to reach US$ 749.05 million, with a 5.5% CAGR. Globally, MF is becoming more common, and early detection is driving market growth. Furthermore, increased R&D activity by key players will create lucrative opportunities for Myelofibrosis (MF) Treatment market growth. Myelofibrosis is distinguished by the presence …
Cystic Fibrosis Therapeutics Market Aims for US$ 116.42 Billion Valuation by 2033 in Reviving Respiratory Health
In 2023, the global Cystic Fibrosis Therapeutics Market is expected to be worth US$ 12.5 billion. The overall demand for Cystic Fibrosis is expected to grow at a CAGR of 25.0% between 2023 and 2033, totaling around US$ 116.42 Billion by 2033, with the implementation of innovative treatment options for early detection. The rising prevalence …
Increasing Prevalence of CKD and ESRD Driving Growth of Kidney Transplant Market is estimated to reach US$ 9.1 Billion by 2033 | FMI
The global kidney transplant market is expected to grow from US$ 5.80 billion in 2023 to US$ 9.1 billion by 2033, at a CAGR of 4.2% during the forecast period. The growth of the market is attributed to the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), rising demand for kidney …
Hypophosphatasia Treatment Market: Unleashing Bone Resilience with a US$ 26.27 Million Valuation by 2033
The hypophosphatasia treatment market worldwide is anticipated to reach US$ 16.13 million in 2023. The overall demand for hypophosphatasia treatments is anticipated to increase at a 5.0% CAGR between 2023 and 2033 due to rising alcohol consumption, reaching approximately US$ 26.27 million by that year. Furthermore, factors such as increased government and non-profit initiatives in …
Cell and Gene Therapy Clinical Trial Market: Charting a Path to a Remarkable US$ 119.3 Billion Valuation by 2032
The global cell and gene therapy clinical trial market will be worth US$10.7 billion in 2021, predicts Future Market Insights’ most recent analysis report on the market. The market is anticipated to grow at a CAGR of 24.9% from 2022 to 2032, reaching a value of US$119.3 billion. With a CAGR of more than 24.9% …